About Neil Giugno
Form D filings for Phi Therapeutics from 2023 to 2024 list Neil Giugno as chief executive officer and director.
Neil Giugno first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Neil Giugno in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Neil Giugno works with at each company, as listed on that company's latest Form D.
Phi Therapeutics, Inc. · Form D/A, Jun 26, 2024